For example, in the SELECT trial (17,600 patients with cardiovascular disease and obesity but without T2D), weekly subcutaneous Semaglutide (2.4 mg) reduced the risk of major adverse cardiovascular events (MACE heart attack, stroke, or cardiovascular death) by 20% compared to placebo (HR 0.80
How long do you stay on GLP-1 oral liquid
While losing weight is an effect of the drug itself, its also due to diet changes caused by GLP-1s (3)
Myth GLP-1 medications are a quick fix Myth Everyone loses weight in the same way Myth GLP-1 medications simply "turn off hunger" Myth Online programs offer the same care as medical clinics
Retatrutide helps your body change the way it uses energy too
It captures attention, drives media coverage, and dominates patient conversations